|
|
Genta Stock Price GNTACompany Description : A biopharmaceutical company engaged in drug research and development and is dedicated to the identification, development and commercialization of drugs for the treatment of cancer and related diseases. url: www.genta.com |
Name:
Genta (MM) |
Symbol:
NASDAQ:GNTA |
Stock Market:
NASDAQ Stock Market |
Type:
Common Stock |
ISIN:
|
Description:
|
| | Change (p) | Change (%) | Cur | Bid | Ask | High | Low | Open | Volume | Time | A | |  | 0.0 | 0.00 | 0.36 | | | | | | | | | |
Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma : BERKELEY HEIGHTS, N.J., Sept. 15 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC:GNTA) (BULLETIN BOARD: GNTA) announced today that the independent Data Monitoring Board (DMB) for AGENDA, a Phase 3 trial of the Company's...
Free Genta Stock ChartsGenta Historical Stock Chart
 |
| Genta Monthly Stock Chart
 | Genta Intraday stock chart
 |  Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.
Get the Latest Genta stock Price, quotes, trades and FREE Genta stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Genta (GNTA) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards. | | Genta News & Message Board Discussion
| Latest Genta News Headlines | | Date | Time | Source | | | 09/15/2008 | 8:05AM | PRNUS | Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma |
| 08/07/2008 | 7:00AM | PRNUS | Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights |
| 07/31/2008 | 8:00AM | PRNUS | Genta Announces Second Quarter 2008 Financial Results and Conference Call |
| 07/15/2008 | 9:20AM | PRNUS | BeaconEquity.com Issues TraderNotes on Active Stocks: CELI, UVSE, GSPG, GNTA, AAPL, IMMU, EXAS, EEE |
| 07/14/2008 | 8:05AM | PRNUS | FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia |
| 07/08/2008 | 10:00AM | PRNUS | BeaconEquity.com Issues TraderNotes on Active Stocks: REGRF, PASO, QMNM, UAUA, CBAK, SMOD, GNTA, YHOO |
| 07/03/2008 | 9:20AM | PRNUS | BeaconEquity.com Issues TraderNotes on Active Stocks: ERII, EXTR, IDXX, NSTR, CMLS, JAKK, MPWR, GNTA |
| 06/24/2008 | 8:00AM | PRNUS | Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma |
| 06/23/2008 | 8:17AM | PRNUS | FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane |
| 06/10/2008 | 8:00AM | PRNUS | Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxa |
| 06/09/2008 | 8:55PM | PRNUS | Genta Announces First Closing of its $40 Million Convertible Financing Facility; Issues $20 Million in Senior Secured Convertibl |
| 06/06/2008 | 8:00AM | PRNUS | Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia |
| | Latest Message Board Discussions | | Date | Time | Source | | | 12/22/2006 | 4:37PM | Free | Genta Pharmaceuticals cuts more than a third of its workforce |
| 08/31/2006 | 8:44AM | Free | GNTA will be a multi bagger in 2006 |
|
Genta Company Information| Sector | Turnover (m) | Profit (m) | EPS - Basic | PE ratio | Mkt Cap (m) | NMS | | | 0.00 | 0.00 | | | 0.0 | N/A |
| Register for FREE access to the latest Genta company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales. |
Latest Genta Stock Trade| Type | Size | Price | Date | Tr.Time | Units | | | | | | | USD |
|
|
| |